| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
5 |
| Employees |
26 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-28 |
| Cash Flow (TTM) (Millions $) |
-1 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Panbela Therapeutics Inc. is a clinical-stage biotechnology company that specializes in the development of targeted therapeutics for the treatment of various cancers. The company focuses on utilizing its proprietary platform technology, known as the Panbela Platform, which combines multiple drugs into a single, potent therapeutic agent.
Through its unique platform, Panbela Therapeutics aims to enhance the effectiveness of cancer treatments while minimizing the side effects typically associated with chemotherapy and other conventional treatments. The company's drug candidates are designed to target specific cancer cells, ensuring precise and efficient treatment.
Panbela Therapeutics conducts extensive research and development to identify and develop innovative therapies for different types of cancers. The company is committed to improving patient outcomes and achieving significant advancements in cancer treatments.
Overall, Panbela Therapeutics Inc. is a biotechnology company at the forefront of developing transformative therapies to combat cancer, offering new hope and potential solutions for patients worldwide.
Company Address: 712 Vista Blvd #305 Waconia 55387 MN
Company Phone Number: 479-1196 Stock Exchange / Ticker: PBLA
|
0.000%
1.09%